On March 31, 2025, LifeLabs Genetics will complete the FastTRK Testing Program funded by Bayer Inc. LifeLabs will continue to offer NTRK fusion testing as part of our molecular pathology services, including specimens submitted for testing under guidelines established and funded by the Ontario Health Cancer Care Ontario program.

We thank you for your business with regards to the FastTRK test at LifeLabs. Since 2019, more than 500 healthcare providers have engaged with the FastTRK program, enabling over 4000 biomarker tests.

In Ontario, LifeLabs is a designated testing site for Ontario Health’s (Cancer Care Ontario) comprehensive cancer testing and diagnosis. For covered tests, please review Ontario Health’s website.  Healthcare providers and/or patients from outside Ontario may contact Ask.Genetics@lifelabs.com or 1-844-GENEHELP (1-844-363-4357) for details how LifeLabs can further support testing.  You can also find more information on our website.

We thank you again for choosing LifeLabs, and we’re here to support you and your patients if you have any questions during this transition.

Thank you,

LifeLabs